Variability of insulin degludec and glargine 300 U/mL: A matter of methodology or just marketing?
Author:
Affiliation:
1. Profil; Neuss Germany
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13365/fullpdf
Reference17 articles.
1. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes;Heise;Diabetes,2004
2. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes;Heise;Diabetes Obes Metab,2012
3. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges;Davies;Int J Obes Relat Metab Disord,2004
4. Subcutaneous insulin: pharmacokinetic variability and glycemic variability;Guerci;Diabetes Metab,2005
5. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long- acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro;Lepore;Diabetes,2000
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glargine-300: An updated literature review on randomized controlled trials and real-world studies;World Journal of Diabetes;2020-04-15
2. Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation;Diabetes & Metabolism;2019-09
3. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2019-02
4. Are newer insulin analogues better for people with Type 1 diabetes?;Diabetic Medicine;2019-01-21
5. Pharmacokinetic and Pharmacodynamic Assessment of Novel and Biosimilar Insulins;Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3